| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | tyrosine-ester sulfotransferase activity | 3.77e-09 | 4 | 158 | 4 | GO:0017067 | |
| GeneOntologyMolecularFunction | amine sulfotransferase activity | 3.77e-09 | 4 | 158 | 4 | GO:0047685 | |
| GeneOntologyMolecularFunction | aryl sulfotransferase activity | 7.11e-09 | 10 | 158 | 5 | GO:0004062 | |
| GeneOntologyMolecularFunction | flavonol 3-sulfotransferase activity | 1.88e-08 | 5 | 158 | 4 | GO:0047894 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | TBC1D3E ADAP1 TBC1D3 PDE6D TBC1D3H TBC1D3L RHOD TBC1D3D MYO9A GRB2 TBC1D3C TBC1D3B KRIT1 DOCK7 RP2 TBC1D3G CYTH4 TBC1D3K TBC1D3F | 2.12e-08 | 507 | 158 | 19 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | TBC1D3E ADAP1 TBC1D3 PDE6D TBC1D3H TBC1D3L RHOD TBC1D3D MYO9A GRB2 TBC1D3C TBC1D3B KRIT1 DOCK7 RP2 TBC1D3G CYTH4 TBC1D3K TBC1D3F | 2.12e-08 | 507 | 158 | 19 | GO:0030695 |
| GeneOntologyMolecularFunction | 3'-phosphoadenosine 5'-phosphosulfate binding | 3.56e-08 | 13 | 158 | 5 | GO:0050656 | |
| GeneOntologyMolecularFunction | steroid sulfotransferase activity | 1.30e-07 | 7 | 158 | 4 | GO:0050294 | |
| GeneOntologyMolecularFunction | GTPase activator activity | TBC1D3E ADAP1 TBC1D3 TBC1D3H TBC1D3L TBC1D3D MYO9A TBC1D3C TBC1D3B RP2 TBC1D3G TBC1D3K TBC1D3F | 3.56e-07 | 279 | 158 | 13 | GO:0005096 |
| GeneOntologyMolecularFunction | sulfate binding | 4.61e-07 | 9 | 158 | 4 | GO:0043199 | |
| GeneOntologyMolecularFunction | transferase activity, transferring sulphur-containing groups | 1.96e-06 | 74 | 158 | 7 | GO:0016782 | |
| GeneOntologyMolecularFunction | sulfotransferase activity | 4.70e-06 | 55 | 158 | 6 | GO:0008146 | |
| GeneOntologyMolecularFunction | single-stranded DNA binding | 9.63e-05 | 134 | 158 | 7 | GO:0003697 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | DHX36 MYH11 MYO5A SLC27A6 MYO9A SMC2 HSPA13 RECQL5 ERCC6L2 MACF1 DDX20 SLFN11 HSPA4 TOP2B DNAH11 | 1.12e-04 | 614 | 158 | 15 | GO:0140657 |
| GeneOntologyMolecularFunction | enzyme regulator activity | TBC1D3E ADAP1 TBC1D3 PDE6D WARS1 TBC1D3H TBC1D3L RHOD TBC1D3D MYO9A GRB2 PSMD2 TBC1D3C TBC1D3B SERPINA12 KRIT1 DOCK7 RP2 C5 TBC1D3G CYTH4 TBC1D3K TBC1D3F | 7.93e-04 | 1418 | 158 | 23 | GO:0030234 |
| GeneOntologyMolecularFunction | isomerase activity | 8.56e-04 | 192 | 158 | 7 | GO:0016853 | |
| GeneOntologyMolecularFunction | beta-glucosidase activity | 9.14e-04 | 6 | 158 | 2 | GO:0008422 | |
| GeneOntologyMolecularFunction | telomerase RNA binding | 9.84e-04 | 25 | 158 | 3 | GO:0070034 | |
| GeneOntologyMolecularFunction | mRNA 5'-UTR binding | 9.84e-04 | 25 | 158 | 3 | GO:0048027 | |
| GeneOntologyBiologicalProcess | activation of GTPase activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B DOCK7 TBC1D3G TBC1D3K TBC1D3F | 6.59e-10 | 109 | 156 | 11 | GO:0090630 |
| GeneOntologyBiologicalProcess | 4-nitrophenol metabolic process | 1.57e-08 | 5 | 156 | 4 | GO:0018960 | |
| GeneOntologyBiologicalProcess | regulation of GTPase activity | TBC1D3E ADAP1 TBC1D3 TBC1D3H TBC1D3L TBC1D3D MYO9A TBC1D3C TBC1D3B DOCK7 TBC1D3G PLXNA2 PLXNB3 TBC1D3K TBC1D3F | 4.03e-08 | 335 | 156 | 15 | GO:0043087 |
| GeneOntologyBiologicalProcess | 3'-phosphoadenosine 5'-phosphosulfate metabolic process | 1.33e-07 | 17 | 156 | 5 | GO:0050427 | |
| GeneOntologyBiologicalProcess | purine ribonucleoside bisphosphate metabolic process | 1.33e-07 | 17 | 156 | 5 | GO:0034035 | |
| GeneOntologyBiologicalProcess | positive regulation of GTPase activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D MYO9A TBC1D3C TBC1D3B DOCK7 TBC1D3G TBC1D3K TBC1D3F | 3.58e-07 | 244 | 156 | 12 | GO:0043547 |
| GeneOntologyBiologicalProcess | sulfation | 1.64e-06 | 27 | 156 | 5 | GO:0051923 | |
| GeneOntologyBiologicalProcess | flavonoid metabolic process | 2.13e-06 | 13 | 156 | 4 | GO:0009812 | |
| GeneOntologyBiologicalProcess | ethanol catabolic process | 6.94e-06 | 17 | 156 | 4 | GO:0006068 | |
| GeneOntologyBiologicalProcess | ethanol metabolic process | 8.87e-06 | 18 | 156 | 4 | GO:0006067 | |
| GeneOntologyBiologicalProcess | regulation of hydrolase activity | TBC1D3E ADAP1 TBC1D3 TBC1D3H TBC1D3L NRDC TBC1D3D MYO9A TBC1D3C TBC1D3B SERPINA12 TP63 VCAN DOCK7 PAX2 TBC1D3G PLXNA2 PLXNB3 TBC1D3K TBC1D3F | 1.09e-05 | 878 | 156 | 20 | GO:0051336 |
| GeneOntologyBiologicalProcess | primary alcohol catabolic process | 2.49e-05 | 23 | 156 | 4 | GO:0034310 | |
| GeneOntologyBiologicalProcess | visual perception | 6.58e-05 | 230 | 156 | 9 | GO:0007601 | |
| GeneOntologyBiologicalProcess | sensory perception of light stimulus | 7.26e-05 | 233 | 156 | 9 | GO:0050953 | |
| GeneOntologyBiologicalProcess | response to xenobiotic stimulus | GAD2 ACACB CYP2J2 RPS6KB1 XPC LCT SULT1A2 SULT1A4 SULT1A1 SULT1A3 SULT1C3 RECQL5 HDAC2 | 1.84e-04 | 525 | 156 | 13 | GO:0009410 |
| GeneOntologyBiologicalProcess | organic hydroxy compound catabolic process | 2.30e-04 | 73 | 156 | 5 | GO:1901616 | |
| GeneOntologyBiologicalProcess | catechol-containing compound metabolic process | 2.46e-04 | 74 | 156 | 5 | GO:0009712 | |
| GeneOntologyBiologicalProcess | catecholamine metabolic process | 2.46e-04 | 74 | 156 | 5 | GO:0006584 | |
| Domain | TBC | TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3G TBC1D3K TBC1D3F | 2.87e-10 | 49 | 159 | 9 | SM00164 |
| Domain | RabGAP-TBC | TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3G TBC1D3K TBC1D3F | 6.02e-10 | 53 | 159 | 9 | PF00566 |
| Domain | Rab-GTPase-TBC_dom | TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3G TBC1D3K TBC1D3F | 8.51e-10 | 55 | 159 | 9 | IPR000195 |
| Domain | TBC_RABGAP | TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3G TBC1D3K TBC1D3F | 8.51e-10 | 55 | 159 | 9 | PS50086 |
| Domain | Sulfotransfer_1 | 5.46e-07 | 36 | 159 | 6 | PF00685 | |
| Domain | Sulfotransferase_dom | 5.46e-07 | 36 | 159 | 6 | IPR000863 | |
| Domain | Elf-1_N | 6.05e-07 | 3 | 159 | 3 | PF12310 | |
| Domain | TF_Elf_N | 6.05e-07 | 3 | 159 | 3 | IPR022084 | |
| Domain | PAX | 6.16e-07 | 9 | 159 | 4 | SM00351 | |
| Domain | PAIRED_2 | 6.16e-07 | 9 | 159 | 4 | PS51057 | |
| Domain | PAIRED_1 | 6.16e-07 | 9 | 159 | 4 | PS00034 | |
| Domain | Paired_dom | 6.16e-07 | 9 | 159 | 4 | IPR001523 | |
| Domain | PAX | 6.16e-07 | 9 | 159 | 4 | PF00292 | |
| Domain | LRRC37AB_C | 2.41e-06 | 4 | 159 | 3 | IPR029423 | |
| Domain | LRRC37AB_C | 2.41e-06 | 4 | 159 | 3 | PF14914 | |
| Domain | LRRC37_N | 2.41e-06 | 4 | 159 | 3 | IPR032754 | |
| Domain | LRRC37 | 2.41e-06 | 4 | 159 | 3 | PF15779 | |
| Domain | LRRC37A/B-like | 2.41e-06 | 4 | 159 | 3 | IPR015753 | |
| Domain | WHTH_DNA-bd_dom | 4.37e-05 | 242 | 159 | 10 | IPR011991 | |
| Domain | Pax7_C | 7.20e-05 | 2 | 159 | 2 | IPR022106 | |
| Domain | Pax7 | 7.20e-05 | 2 | 159 | 2 | PF12360 | |
| Domain | - | 1.07e-04 | 218 | 159 | 9 | 1.10.10.10 | |
| Domain | Pax2_C | 2.15e-04 | 3 | 159 | 2 | IPR022130 | |
| Domain | Pax2_C | 2.15e-04 | 3 | 159 | 2 | PF12403 | |
| Domain | Glyco_hydro_1_N_CS | 4.27e-04 | 4 | 159 | 2 | IPR033132 | |
| Domain | Glyco_hydro_1_AS | 4.27e-04 | 4 | 159 | 2 | IPR018120 | |
| Domain | GLYCOSYL_HYDROL_F1_1 | 7.08e-04 | 5 | 159 | 2 | PS00572 | |
| Domain | Glyco_hydro_1 | 7.08e-04 | 5 | 159 | 2 | PF00232 | |
| Domain | Myosin_S1_N | 7.08e-04 | 5 | 159 | 2 | IPR008989 | |
| Domain | GLYCOSYL_HYDROL_F1_2 | 7.08e-04 | 5 | 159 | 2 | PS00653 | |
| Domain | Glyco_hydro_1 | 7.08e-04 | 5 | 159 | 2 | IPR001360 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_PHIP_TO_DNA_ADDUCTS | 2.93e-08 | 5 | 125 | 4 | M47807 | |
| Pathway | WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3C TBC1D3B SLFN11 TBC1D3G TBC1D3K | 2.24e-07 | 99 | 125 | 9 | M46448 |
| Pathway | KEGG_SULFUR_METABOLISM | 3.96e-06 | 13 | 125 | 4 | M18256 | |
| Pathway | WP_SULFATION_BIOTRANSFORMATION_REACTION | 1.28e-05 | 17 | 125 | 4 | M39483 | |
| Pathway | REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_BCR_SIGNALING | 1.34e-05 | 6 | 125 | 3 | M27798 | |
| Pathway | WP_ESTROGEN_METABOLISM | 3.81e-05 | 22 | 125 | 4 | MM15888 | |
| Pathway | REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES | 4.58e-05 | 23 | 125 | 4 | MM14597 | |
| Pathway | REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES | 5.46e-05 | 24 | 125 | 4 | M16289 | |
| Pubmed | TBC1D3, a hominoid oncoprotein, is encoded by a cluster of paralogues located on chromosome 17q12. | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3G TBC1D3K TBC1D3F | 3.73e-23 | 11 | 161 | 10 | 16863688 |
| Pubmed | 4.42e-10 | 4 | 161 | 4 | 24318996 | ||
| Pubmed | 4.42e-10 | 4 | 161 | 4 | 33414449 | ||
| Pubmed | 4.42e-10 | 4 | 161 | 4 | 8943792 | ||
| Pubmed | A single mutation converts the nucleotide specificity of phenol sulfotransferase from PAP to AMP. | 4.42e-10 | 4 | 161 | 4 | 12390022 | |
| Pubmed | 4.42e-10 | 4 | 161 | 4 | 8424956 | ||
| Pubmed | 4.42e-10 | 4 | 161 | 4 | 8288252 | ||
| Pubmed | 4.42e-10 | 4 | 161 | 4 | 25370010 | ||
| Pubmed | 4.94e-10 | 10 | 161 | 5 | 7601475 | ||
| Pubmed | DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage. | TBC1D3E TBC1D3 TBC1D3H TBC1D3D LRRC37A2 TBC1D3B TBC1D3G TBC1D3F | 2.06e-09 | 74 | 161 | 8 | 16625196 |
| Pubmed | 2.20e-09 | 5 | 161 | 4 | 11389699 | ||
| Pubmed | 2.20e-09 | 5 | 161 | 4 | 29908303 | ||
| Pubmed | 2.20e-09 | 5 | 161 | 4 | 25053625 | ||
| Pubmed | 2.20e-09 | 5 | 161 | 4 | 24802129 | ||
| Pubmed | Structural and chemical profiling of the human cytosolic sulfotransferases. | 2.49e-09 | 13 | 161 | 5 | 17425406 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DHX36 DNAJC13 MIS18BP1 WARS1 MYO5A MYO9A RPS3A PHF6 PSMD2 XPC AGPS MCM10 SMC2 MYEF2 SLC25A3 LRPPRC FUBP1 UTP4 RECQL5 MACF1 DDX20 SLC25A11 WDFY3 HSPA4 TOP2B | 3.78e-09 | 1353 | 161 | 25 | 29467282 |
| Pubmed | Roles of Pax-genes in developing and adult brain as suggested by expression patterns. | 6.59e-09 | 6 | 161 | 4 | 8126546 | |
| Pubmed | DHX36 MYH11 DNAJC13 WARS1 NRCAM NRDC MYO5A MAP2 MYO9A RPS3A GRB2 PSMD2 MYEF2 SLC25A3 SPTBN4 LRPPRC EPS15L1 VCAN DOCK7 SYP MACF1 PRKCG SLC25A11 HSPA4 DNAH11 | 1.15e-08 | 1431 | 161 | 25 | 37142655 | |
| Pubmed | 1.53e-08 | 7 | 161 | 4 | 12438748 | ||
| Pubmed | 1.53e-08 | 7 | 161 | 4 | 9370299 | ||
| Pubmed | Alternative splicing, gene localization, and binding of SH2-B to the insulin receptor kinase domain. | 3.05e-08 | 8 | 161 | 4 | 10594240 | |
| Pubmed | 3.83e-08 | 21 | 161 | 5 | 32301970 | ||
| Pubmed | 5.47e-08 | 9 | 161 | 4 | 8887328 | ||
| Pubmed | Ethanol sulfation by the human cytosolic sulfotransferases: a systematic analysis. | 5.47e-08 | 9 | 161 | 4 | 23207770 | |
| Pubmed | 5.47e-08 | 9 | 161 | 4 | 19548878 | ||
| Pubmed | 5.47e-08 | 9 | 161 | 4 | 7883790 | ||
| Pubmed | 5.47e-08 | 9 | 161 | 4 | 10197584 | ||
| Pubmed | 5.47e-08 | 9 | 161 | 4 | 9177785 | ||
| Pubmed | 5.47e-08 | 9 | 161 | 4 | 9166597 | ||
| Pubmed | Chromosomal localization of seven PAX genes and cloning of a novel family member, PAX-9. | 5.47e-08 | 9 | 161 | 4 | 7981748 | |
| Pubmed | 5.47e-08 | 9 | 161 | 4 | 8468045 | ||
| Pubmed | Chromosomal localization of the mouse genes encoding the ERK1 and ERK2 isoforms of MAP kinases. | 5.47e-08 | 9 | 161 | 4 | 9060415 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | MYO5A RPS3A GRK6 PSMD2 AGPS SMC2 MYEF2 SLC25A3 LRPPRC SUPT5H FUBP1 UTP4 DOCK7 CSTF3 MACF1 RP2 HSPA4 TOP2B HDAC2 RBM17 | 6.52e-08 | 1024 | 161 | 20 | 24711643 |
| Pubmed | Identification of two human brain aryl sulfotransferase cDNAs. | 9.74e-08 | 3 | 161 | 3 | 8363592 | |
| Pubmed | 9.74e-08 | 3 | 161 | 3 | 9855620 | ||
| Pubmed | 9.74e-08 | 3 | 161 | 3 | 8912648 | ||
| Pubmed | ATRN GAD2 WARS1 NRCAM MYO5A ACO1 ANKRD49 PSMD2 XPC ZFC3H1 ANKRD6 KRIT1 HSPA13 SCYL2 SPTBN4 EPS15L1 SUPT5H MACF1 DGCR8 WDFY3 DNAI7 PLXNB3 | 1.35e-07 | 1285 | 161 | 22 | 35914814 | |
| Pubmed | Pax3 Hypomorphs Reveal Hidden Pax7 Functional Genetic Compensation in Utero. | 1.42e-07 | 11 | 161 | 4 | 35645295 | |
| Pubmed | Homeobox genes: a link between development, cell cycle, and cancer? | 1.42e-07 | 11 | 161 | 4 | 10328847 | |
| Pubmed | Localization of the murine cholecystokinin A and B receptor genes. | 1.42e-07 | 11 | 161 | 4 | 7613026 | |
| Pubmed | 1.42e-07 | 11 | 161 | 4 | 11154739 | ||
| Pubmed | Tbx6, a mouse T-Box gene implicated in paraxial mesoderm formation at gastrulation. | 1.42e-07 | 11 | 161 | 4 | 8954725 | |
| Pubmed | Sulfation and sulfotransferases 1: Sulfotransferase molecular biology: cDNAs and genes. | 1.42e-07 | 11 | 161 | 4 | 9034160 | |
| Pubmed | 1.42e-07 | 11 | 161 | 4 | 10720750 | ||
| Pubmed | Identification of four chromosomal loci determining obesity in a multifactorial mouse model. | 2.13e-07 | 12 | 161 | 4 | 7706460 | |
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | MYH11 MYO5A MAP2 RPS3A PSMD2 SMC2 ATL1 SLC25A3 EPS15L1 MYL9 PTPRE ADAMTS20 SYP PRKCG SLC25A11 | 2.27e-07 | 621 | 161 | 15 | 22794259 |
| Pubmed | 3.06e-07 | 13 | 161 | 4 | 10585447 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | WARS1 ACACB RAPH1 RPS3A PHF6 SCYL2 SLC25A3 EPS15L1 UTP4 NCOA7 MACF1 ELF2 SLFN11 EIF3G HSPA4 TOP2B PUS7 RBM17 | 3.77e-07 | 934 | 161 | 18 | 33916271 |
| Pubmed | 3.88e-07 | 4 | 161 | 3 | 27188442 | ||
| Pubmed | 3.88e-07 | 4 | 161 | 3 | 22419166 | ||
| Pubmed | 3.88e-07 | 4 | 161 | 3 | 26207754 | ||
| Pubmed | 3.88e-07 | 4 | 161 | 3 | 32152050 | ||
| Pubmed | 3.88e-07 | 4 | 161 | 3 | 8661000 | ||
| Pubmed | PRC17, a novel oncogene encoding a Rab GTPase-activating protein, is amplified in prostate cancer. | 3.88e-07 | 4 | 161 | 3 | 12359748 | |
| Pubmed | 3.88e-07 | 4 | 161 | 3 | 8406013 | ||
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | DHX36 MYO9A RPS3A PARP2 PHF6 ZFC3H1 SMC2 STN1 SLC25A3 LRPPRC UTP4 DDX20 SLC25A11 | 4.83e-07 | 486 | 161 | 13 | 30940648 |
| Pubmed | 5.80e-07 | 15 | 161 | 4 | 1741163 | ||
| Pubmed | Pax: a murine multigene family of paired box-containing genes. | 5.80e-07 | 15 | 161 | 4 | 1685142 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | DHX36 DNAJC13 MAP2 RPS3A XPC AGPS MYEF2 SLC25A3 LRPPRC SUPT5H VCAN DOCK7 CSTF3 MACF1 SLC25A11 KDM1B TOP2B HDAC2 RBM17 | 7.12e-07 | 1082 | 161 | 19 | 38697112 |
| Pubmed | 7.19e-07 | 156 | 161 | 8 | 32850835 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | DHX36 WARS1 ACACB RPS3A PARP2 PHF6 PSMD2 AGPS SMC2 SLC25A3 LRPPRC FUBP1 UTP4 NOP10 DDX20 SLC25A11 EIF3G HSPA4 LRIF1 TOP2B HDAC2 | 8.53e-07 | 1318 | 161 | 21 | 30463901 |
| Pubmed | 9.67e-07 | 5 | 161 | 3 | 12604796 | ||
| Pubmed | 9.67e-07 | 5 | 161 | 3 | 10207087 | ||
| Pubmed | 9.67e-07 | 5 | 161 | 3 | 8471161 | ||
| Pubmed | 1.00e-06 | 17 | 161 | 4 | 20395553 | ||
| Pubmed | 1.29e-06 | 18 | 161 | 4 | 20056724 | ||
| Pubmed | 1.62e-06 | 19 | 161 | 4 | 8575294 | ||
| Pubmed | TENT4B RPS6KB1 GRK6 GRB2 SULT1A2 SULT1A4 PTPRE SULT1A1 SULT1A3 SULT1C3 FUBP1 PRKCG KDM1B HDAC2 DNAH11 | 1.71e-06 | 730 | 161 | 15 | 34857952 | |
| Pubmed | DNAJC13 RPS3A PHF6 PSMD2 SMC2 SCYL2 SLC25A3 LRPPRC CSTF3 DDX20 EIF3G HSPA4 TOP2B HDAC2 | 1.80e-06 | 638 | 161 | 14 | 33239621 | |
| Pubmed | 1.93e-06 | 6 | 161 | 3 | 1485966 | ||
| Pubmed | 1.93e-06 | 6 | 161 | 3 | 23760954 | ||
| Pubmed | 1.93e-06 | 6 | 161 | 3 | 14970218 | ||
| Pubmed | Mapping of the human homologs of the murine paired-box-containing genes. | 1.93e-06 | 6 | 161 | 3 | 8431641 | |
| Pubmed | DHX36 WARS1 MYO5A RPS3A PSMD2 MYEF2 LRPPRC SUPT5H UTP4 DOCK7 MACF1 DDX20 HSPA4 HDAC2 | 2.36e-06 | 653 | 161 | 14 | 22586326 | |
| Pubmed | 3.27e-06 | 191 | 161 | 8 | 33762435 | ||
| Pubmed | Mapping of the mouse Ly-6, Xp-14, and Gdc-1 loci to chromosome 15. | 3.36e-06 | 7 | 161 | 3 | 2880797 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | CYP4V2 GABRE ENOSF1 ATRN DNAJC13 MYO5A MAP2 MYO9A RPS6KB1 AGPAT3 PHF6 TULP3 SPTBN4 LRPPRC EPS15L1 PTPRE FUBP1 EXOC6B CSTF3 MACF1 PPIE | 5.74e-06 | 1489 | 161 | 21 | 28611215 |
| Pubmed | DSC2 MYO9A RPS3A PSMD2 SMC2 SCYL2 SLC25A3 LRPPRC EPS15L1 DOCK7 MACF1 SLC25A11 EIF3G HSPA4 | 5.95e-06 | 708 | 161 | 14 | 39231216 | |
| Pubmed | GAD2 WARS1 ACACB NRCAM MYO5A MAP2 PSMD2 MYEF2 ATL1 LRPPRC EPS15L1 DOCK7 SYP MACF1 PRKCG SLC25A11 HDAC2 RBM17 | 6.14e-06 | 1139 | 161 | 18 | 36417873 | |
| Pubmed | 8.01e-06 | 9 | 161 | 3 | 9858722 | ||
| Pubmed | 8.01e-06 | 9 | 161 | 3 | 15520281 | ||
| Pubmed | PSMD2 ZFC3H1 MCM10 STN1 SLC25A3 FUBP1 RECQL5 CSTF3 DDX20 DGCR8 KDM1B | 9.38e-06 | 453 | 161 | 11 | 29656893 | |
| Pubmed | GRWD1 regulates ribosomal protein L23 levels via the ubiquitin-proteasome system. | 9.55e-06 | 221 | 161 | 8 | 29991511 | |
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | 9.62e-06 | 370 | 161 | 10 | 22922362 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | DHX36 TENT4B WARS1 NRDC RPS3A PHF6 PSMD2 AGPS SMC2 SLC25A3 LRPPRC SUPT5H FUBP1 UTP4 DOCK7 CSTF3 DDX20 SLC25A11 HSPA4 TOP2B | 1.05e-05 | 1425 | 161 | 20 | 30948266 |
| Pubmed | DHX36 ACACB MYO5A RPS3A PHF6 PSMD2 FUBP1 RECQL5 ELF1 ELF2 ELF4 SLC25A11 PAX2 PAX7 EIF3G KDM1B ZNF709 HSPA4 LRIF1 HDAC2 | 1.09e-05 | 1429 | 161 | 20 | 35140242 | |
| Pubmed | 1.14e-05 | 10 | 161 | 3 | 23064749 | ||
| Pubmed | Human cytosolic sulphotransferases: genetics, characteristics, toxicological aspects. | 1.14e-05 | 10 | 161 | 3 | 11535246 | |
| Pubmed | RPS3A PSMD2 SMC2 SCYL2 SLC25A3 DDX20 SLC25A11 EIF3G HSPA4 RBM17 | 1.30e-05 | 383 | 161 | 10 | 29331416 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | DHX36 DNAJC13 TENT4B MYO5A RPS3A PHF6 ZFC3H1 MCM10 SMC2 MACF1 SLC25A11 DGCR8 TOP2B RBM17 | 1.30e-05 | 759 | 161 | 14 | 35915203 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | DHX36 TENT4B RPS3A PARP2 PHF6 PSMD2 MCM10 SLC25A3 LRPPRC SUPT5H FUBP1 UTP4 DGCR8 HSPA4 TOP2B HDAC2 | 1.56e-05 | 989 | 161 | 16 | 36424410 |
| Pubmed | Pax2/5 and Pax6 subdivide the early neural tube into three domains. | 1.56e-05 | 11 | 161 | 3 | 10354469 | |
| Pubmed | MYH11 PHF6 PSMD2 AGPS SCYL2 SLC25A3 LRPPRC FUBP1 CSTF3 NOP10 SLC25A11 EIF3G HSPA4 TOP2B | 1.91e-05 | 786 | 161 | 14 | 29128334 | |
| Pubmed | Cerebral cavernous malformations are driven by ADAMTS5 proteolysis of versican. | 2.08e-05 | 12 | 161 | 3 | 32648916 | |
| Pubmed | 2.08e-05 | 12 | 161 | 3 | 28625870 | ||
| Pubmed | TENT4B RHOD MYO5A PARP2 PHF6 XPC ZFC3H1 MYEF2 SLC25A3 UTP4 RECQL5 CSTF3 MACF1 NOP10 DDX20 PPIE SLC25A11 DGCR8 EIF3G KDM1B | 2.12e-05 | 1497 | 161 | 20 | 31527615 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 28331227 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 9016952 | ||
| Pubmed | Active site mutations and substrate inhibition in human sulfotransferase 1A1 and 1A3. | 2.13e-05 | 2 | 161 | 2 | 14871892 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 9524226 | ||
| Interaction | SULT1A3 interactions | 9.84e-07 | 24 | 156 | 5 | int:SULT1A3 | |
| Interaction | BRD7 interactions | DHX36 MYO9A RPS3A PARP2 PHF6 ZFC3H1 SMC2 WDR76 STN1 SLC25A3 LRPPRC UTP4 ELF1 ELF4 DDX20 SLC25A11 PAX2 LRIF1 | 2.27e-06 | 637 | 156 | 18 | int:BRD7 |
| Interaction | TRIM52 interactions | 9.31e-06 | 133 | 156 | 8 | int:TRIM52 | |
| Interaction | SULT1C2 interactions | 1.22e-05 | 19 | 156 | 4 | int:SULT1C2 | |
| Interaction | SULT1A1 interactions | 1.32e-05 | 67 | 156 | 6 | int:SULT1A1 | |
| Interaction | H2BC8 interactions | MIS18BP1 PARP2 PHF6 XPC MCM10 WDR76 SUPT5H RECQL5 ELF1 ELF2 SLFN11 KDM1B LRIF1 TOP2B PUS7 | 4.27e-05 | 576 | 156 | 15 | int:H2BC8 |
| Interaction | HTT interactions | MYH11 MYO5A MAP2 RPS3A RPS6KB1 GRB2 PSMD2 ZFC3H1 SMC2 ATL1 SLC25A3 EPS15L1 MYL9 PTPRE ADAMTS20 SYP PRKCG SLC25A11 EIF3G HSPA4 | 4.56e-05 | 949 | 156 | 20 | int:HTT |
| Interaction | KCTD13 interactions | DHX36 MYH11 DNAJC13 WARS1 NRCAM NRDC MYO5A MAP2 MYO9A RPS3A GRB2 PSMD2 MYEF2 SLC25A3 SPTBN4 LRPPRC EPS15L1 VCAN DOCK7 SYP MACF1 PRKCG SLC25A11 HSPA4 DNAH11 | 6.91e-05 | 1394 | 156 | 25 | int:KCTD13 |
| Interaction | NAA40 interactions | WARS1 ACACB RAPH1 RPS3A PARP2 PHF6 XPC SCYL2 SLC25A3 EPS15L1 UTP4 NCOA7 MACF1 ELF2 SLFN11 EIF3G HSPA4 TOP2B PUS7 RBM17 | 6.92e-05 | 978 | 156 | 20 | int:NAA40 |
| Interaction | SULT1C3 interactions | 7.17e-05 | 11 | 156 | 3 | int:SULT1C3 | |
| Interaction | TBC1D3G interactions | 7.17e-05 | 11 | 156 | 3 | int:TBC1D3G | |
| Interaction | DNAI7 interactions | 7.17e-05 | 11 | 156 | 3 | int:DNAI7 | |
| Interaction | BAG5 interactions | DNAJC13 WARS1 ACACB NRCAM RPS3A GRK6 PSMD2 SLC25A3 DOCK7 HSPA4 HDAC2 | 7.27e-05 | 341 | 156 | 11 | int:BAG5 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q12 | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B SLFN11 TBC1D3G TBC1D3K TBC1D3F | 6.35e-12 | 149 | 161 | 11 | chr17q12 |
| Cytoband | 17q12 | 1.45e-06 | 99 | 161 | 6 | 17q12 | |
| GeneFamily | Sulfotransferases, cytosolic | 1.67e-08 | 14 | 113 | 5 | 762 | |
| GeneFamily | Paired boxes | 1.78e-07 | 9 | 113 | 4 | 675 | |
| GeneFamily | ETS transcription factor family | 6.95e-04 | 28 | 113 | 3 | 534 | |
| GeneFamily | Plexins | 1.35e-03 | 9 | 113 | 2 | 683 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | DHX36 DNAJC13 MIS18BP1 MOSPD2 MYO5A MYO9A NOX4 SMC2 MYEF2 ATL1 KRIT1 SLC45A2 ZDHHC11 TOP2B HDAC2 RBM17 | 2.63e-06 | 656 | 159 | 16 | M18979 |
| Coexpression | GSE12003_MIR223_KO_VS_WT_BM_PROGENITOR_8D_CULTURE_DN | 3.19e-06 | 146 | 159 | 8 | M392 | |
| Coexpression | GSE4984_UNTREATED_VS_LPS_TREATED_DC_UP | 4.10e-06 | 151 | 159 | 8 | M6498 | |
| Coexpression | VERNOCHET_ADIPOGENESIS | 1.26e-05 | 24 | 159 | 4 | MM1317 | |
| Coexpression | GSE25123_CTRL_VS_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DN | 3.05e-05 | 199 | 159 | 8 | M7998 | |
| CoexpressionAtlas | Mesoderm Day 15_vs_Mesoderm Day 30-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3G TBC1D3K TBC1D3F | 2.48e-08 | 90 | 159 | 9 | PCBC_ratio_MESO-15_vs_MESO-30_cfr-2X-p05 |
| CoexpressionAtlas | Endoderm Differentiated Cells-method_mRNA_vs_Endoderm Differentiated Cells-method_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L RHOD TBC1D3D TBC1D3C TBC1D3B TBC1D3G PLXNA2 TBC1D3K TBC1D3F | 6.31e-07 | 213 | 159 | 11 | PCBC_ratio_DE_from-mRNA_vs_DE_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Endoderm Differentiated Cells-reprogram_OSKM-L_vs_Endoderm Differentiated Cells-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L RHOD TBC1D3D TBC1D3C TBC1D3B TBC1D3G PLXNA2 TBC1D3K TBC1D3F | 6.31e-07 | 213 | 159 | 11 | PCBC_ratio_DE_from-OSKM-L_vs_DE_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L NRCAM TBC1D3D ANKRD6 TBC1D3C TBC1D3B VCAN C5 TBC1D3G TBC1D3K TBC1D3F | 9.11e-07 | 320 | 159 | 13 | PCBC_ratio_MESO-5_vs_DE_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5-reprogram_OSKM-L_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L NRCAM TBC1D3D TBC1D3C TBC1D3B SULT1A4 SULT1A3 TBC1D3G TBC1D3K TBC1D3F | 1.45e-06 | 281 | 159 | 12 | PCBC_ratio_MESO-5_from-OSKM-L_vs_MESO-5_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5-method_mRNA_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L NRCAM TBC1D3D TBC1D3C TBC1D3B SULT1A4 SULT1A3 TBC1D3G TBC1D3K TBC1D3F | 1.45e-06 | 281 | 159 | 12 | PCBC_ratio_MESO-5_from-mRNA_vs_MESO-5_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | DE cord blood_vs_DE blastocyst-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B C5 TBC1D3G PLXNA2 TBC1D3K TBC1D3F | 2.20e-06 | 242 | 159 | 11 | PCBC_ratio_DE cord blood_vs_DE blastocyst_cfr-2X-p05 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000 | NPR3 MOSPD2 DSC2 MYO5A MAP2 SYNPO2L PHF6 ANKRD6 HSPA13 PTPRE TP63 VCAN SCN3A ERCC6L2 PAX3 RP2 PAX7 KDM1B TOP2B | 1.67e-05 | 836 | 159 | 19 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000 |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS-6|TCGA-Stomach / Sample_Type by Project: Shred V9 | 5.11e-07 | 192 | 161 | 8 | 4e689bca7a242f8482e25f273656e2caba8821c0 | |
| ToppCell | IPF-Epithelial-Aberrant_Basaloid|Epithelial / Disease state, Lineage and Cell class | 5.84e-06 | 189 | 161 | 7 | 4178be3292ff4a8a1d8098f638d4b8d15164d2c6 | |
| ToppCell | COVID-19_Convalescent-PLT_4|COVID-19_Convalescent / Disease Group and Platelet Clusters | 6.92e-06 | 194 | 161 | 7 | ce1fad4e76a87f0c35e430ed1f2262395df882fd | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35|World / Primary Cells by Cluster | 7.91e-06 | 198 | 161 | 7 | de5214a85fe017eb23d4aa8af624464f062ec57e | |
| ToppCell | Control-Control-Lymphocyte-T/NK-CD4+_T_activated|Control / Disease, condition lineage and cell class | 7.91e-06 | 198 | 161 | 7 | ee71543559836fd59adc0da877b2ca538cba60cb | |
| Computational | Neighborhood of RPA2 | 5.00e-05 | 193 | 95 | 9 | MORF_RPA2 | |
| Drug | dopamine-4-O-sulfate | 6.93e-08 | 7 | 154 | 4 | CID000123932 | |
| Drug | 2-naphthylsulfate | 6.93e-08 | 7 | 154 | 4 | CID000074428 | |
| Drug | 2-iodo-4-azidophenol | 6.93e-08 | 7 | 154 | 4 | CID003035977 | |
| Drug | luciferyl sulfate | 6.93e-08 | 7 | 154 | 4 | CID011953812 | |
| Drug | dopamine 3-O-sulfate | 1.38e-07 | 8 | 154 | 4 | CID000122136 | |
| Drug | 6-anilino-2-thiouracil | 1.38e-07 | 8 | 154 | 4 | CID003037707 | |
| Drug | 2-iodophenol | 1.38e-07 | 8 | 154 | 4 | CID000010784 | |
| Drug | MeA alpha C | 3.18e-07 | 22 | 154 | 5 | CID000062244 | |
| Drug | d-equilenin | 3.21e-07 | 41 | 154 | 6 | CID000010597 | |
| Drug | AalphaC | 5.08e-07 | 24 | 154 | 5 | CID000062805 | |
| Drug | 2-pentanone | 6.32e-07 | 25 | 154 | 5 | CID000007895 | |
| Drug | 1m2q | 7.78e-07 | 26 | 154 | 5 | CID005326637 | |
| Drug | EM-139 | 1.37e-06 | 13 | 154 | 4 | CID000131427 | |
| Drug | Glu-P-2 | 1.38e-06 | 29 | 154 | 5 | CID000049970 | |
| Drug | naphthalenemethanol | 1.91e-06 | 14 | 154 | 4 | CID000020908 | |
| Drug | deoxoestrone | 1.91e-06 | 14 | 154 | 4 | CID000005888 | |
| Drug | barium hydroxide | 1.96e-06 | 31 | 154 | 5 | CID000028387 | |
| Drug | arylsulfate | 2.59e-06 | 15 | 154 | 4 | CID000074426 | |
| Drug | cyclobenzaprine | 2.59e-06 | 15 | 154 | 4 | CID000002895 | |
| Drug | 4-methylumbelliferone | 3.31e-06 | 132 | 154 | 8 | CID003364573 | |
| Drug | A-44 | 3.44e-06 | 16 | 154 | 4 | CID000120353 | |
| Drug | benzilic acid | 4.47e-06 | 17 | 154 | 4 | CID000006463 | |
| Drug | phenylhydroxylamine | 5.56e-06 | 38 | 154 | 5 | CID000007518 | |
| Drug | AC1Q6OHG | 7.21e-06 | 19 | 154 | 4 | CID000115063 | |
| Drug | pedunculagin | 7.21e-06 | 19 | 154 | 4 | CID000442688 | |
| Drug | E)-4-hydroxytamoxifen | NOX4 KRIT1 SULT1A2 SULT1A4 SULT1A1 SULT1A3 PRKCG SLC45A2 DGCR8 | 8.14e-06 | 197 | 154 | 9 | CID000063062 |
| Drug | PLP-Glu | 8.96e-06 | 20 | 154 | 4 | CID000444293 | |
| Drug | Phosphoadenosine Phosphosulfate | 1.04e-05 | 7 | 154 | 3 | ctd:D010724 | |
| Drug | N-hydroxy-2-aminofluorene | 1.10e-05 | 21 | 154 | 4 | CID000005895 | |
| Drug | AABSSN | 1.34e-05 | 22 | 154 | 4 | CID005464134 | |
| Drug | 1-hydroxymethylpyrene | 1.61e-05 | 23 | 154 | 4 | CID000104977 | |
| Drug | taselin | 1.61e-05 | 23 | 154 | 4 | CID000023846 | |
| Drug | N-hydroxy-4-aminobiphenyl | 1.66e-05 | 8 | 154 | 3 | ctd:C014593 | |
| Drug | pentachlorophenol | 1.77e-05 | 120 | 154 | 7 | CID000000992 | |
| Drug | sulfamethazine | 1.80e-05 | 48 | 154 | 5 | CID000005327 | |
| Drug | AzMC | 2.28e-05 | 25 | 154 | 4 | CID000064986 | |
| Drug | minoxidil sulphate | 2.28e-05 | 25 | 154 | 4 | CID000004202 | |
| Drug | alpha-methyldopamine | 2.68e-05 | 26 | 154 | 4 | CID000017005 | |
| Drug | glycolithocholic acid | 2.68e-05 | 26 | 154 | 4 | CID000115245 | |
| Drug | 9-hydroxybenzo(a)pyrene | 2.93e-05 | 53 | 154 | 5 | CID000028598 | |
| Drug | MeIQx | 3.51e-05 | 55 | 154 | 5 | CID000062275 | |
| Drug | 2-naphthol | 4.08e-05 | 93 | 154 | 6 | CID000008663 | |
| Drug | AC1L1IZ2 | 4.39e-05 | 304 | 154 | 10 | CID000004795 | |
| Drug | Hydroxytryptophol | 4.55e-05 | 2 | 154 | 2 | ctd:D006917 | |
| Drug | 5-hydroxymethylfurfural | 4.55e-05 | 2 | 154 | 2 | ctd:C008046 | |
| Drug | 6-hydroxymelatonin | 4.55e-05 | 2 | 154 | 2 | ctd:C012365 | |
| Drug | 3,3'-T2 | 4.81e-05 | 30 | 154 | 4 | CID000065559 | |
| Drug | 4-hydroxyestrone | 4.95e-05 | 59 | 154 | 5 | CID000018418 | |
| Drug | acetaminophen glucuronide | 4.95e-05 | 59 | 154 | 5 | CID000083944 | |
| Drug | 1-naphthol | 5.48e-05 | 98 | 154 | 6 | CID000007005 | |
| Drug | A2'p5'A2'p5'A | 5.49e-05 | 31 | 154 | 4 | CID000122642 | |
| Drug | acetaminophen sulfate | 5.49e-05 | 31 | 154 | 4 | CID000083939 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HG-U133A | 5.63e-05 | 195 | 154 | 8 | 1785_DN | |
| Drug | Moroxidine hydrochloride [3160-91-6]; Up 200; 19.2uM; PC3; HG-U133A | 5.63e-05 | 195 | 154 | 8 | 1944_UP | |
| Drug | 0198306-0000 [212631-61-3]; Up 200; 10uM; PC3; HT_HG-U133A | 6.05e-05 | 197 | 154 | 8 | 7069_UP | |
| Drug | 1 C2 | 6.13e-05 | 100 | 154 | 6 | CID005327152 | |
| Drug | Clomipramine hydrochloride [17321-77-6]; Down 200; 11.4uM; HL60; HG-U133A | 6.27e-05 | 198 | 154 | 8 | 1566_DN | |
| Drug | 2-nitrosopropane | 6.38e-05 | 12 | 154 | 3 | CID000079121 | |
| Drug | retinoic acid; Down 200; 1uM; MCF7; HG-U133A | 6.50e-05 | 199 | 154 | 8 | 384_DN | |
| Drug | Sparteine (-) [90-39-1]; Up 200; 17uM; HL60; HT_HG-U133A | 6.73e-05 | 200 | 154 | 8 | 2134_UP | |
| Drug | 3-OHBaP | 6.80e-05 | 63 | 154 | 5 | CID000025890 | |
| Drug | DCNP | 7.07e-05 | 33 | 154 | 4 | CID000012066 | |
| Drug | A21250 | 8.05e-05 | 105 | 154 | 6 | CID000000990 | |
| Drug | DNOC | 8.95e-05 | 35 | 154 | 4 | CID000010800 | |
| Drug | mefenamic acid | 1.12e-04 | 37 | 154 | 4 | CID000004044 | |
| Drug | galangin | 1.12e-04 | 37 | 154 | 4 | CID005281616 | |
| Drug | Pyrethroids | 1.21e-04 | 71 | 154 | 5 | CID000005053 | |
| Drug | 8-azaadenine | 1.36e-04 | 3 | 154 | 2 | ctd:C006654 | |
| Drug | 3,3'-diiodothyronine | 1.36e-04 | 3 | 154 | 2 | ctd:C030629 | |
| Drug | 5-hydroxy-3-methylindole | 1.36e-04 | 3 | 154 | 2 | CID000192734 | |
| Drug | 5-hydroxyindole | 1.36e-04 | 3 | 154 | 2 | ctd:C026785 | |
| Drug | Minoxidil | 1.36e-04 | 3 | 154 | 2 | ctd:D008914 | |
| Drug | beta-methyllanthionine | 1.36e-04 | 3 | 154 | 2 | CID000191096 | |
| Drug | AC1NS1PS | 1.38e-04 | 39 | 154 | 4 | CID005327133 | |
| Drug | thapsigargin; Up 200; 0.1uM; MCF7; HT_HG-U133A | 1.50e-04 | 168 | 154 | 7 | 7100_UP | |
| Drug | 7-hydroxycoumarin | 1.56e-04 | 75 | 154 | 5 | CID005281426 | |
| Drug | propane 2-nitronate | 1.59e-04 | 16 | 154 | 3 | CID000107791 | |
| Drug | LY294002 | MYH11 WIPI1 MYO5A CYP2J2 RPS6KB1 PARP2 GRB2 NOX4 MYEF2 KRIT1 PIK3C2B PRKCG ELF4 C5 HSPA4 | 1.75e-04 | 748 | 154 | 15 | CID000003973 |
| Drug | L-alpha-methyldopa | 1.84e-04 | 42 | 154 | 4 | CID000004138 | |
| Drug | benzyloxyresorufin | 1.88e-04 | 78 | 154 | 5 | CID000114982 | |
| Drug | PhIP-HCl | 1.92e-04 | 123 | 154 | 6 | CID000001530 | |
| Drug | SR 27897 | 1.92e-04 | 17 | 154 | 3 | CID000122077 | |
| Drug | betulin | 1.92e-04 | 17 | 154 | 3 | CID000072326 | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A | 1.93e-04 | 175 | 154 | 7 | 5222_UP | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 1.93e-04 | 175 | 154 | 7 | 1058_DN | |
| Drug | 4-hydroxyestradiol | 2.00e-04 | 79 | 154 | 5 | CID000001743 | |
| Drug | Woodward's reagent K | 2.02e-04 | 43 | 154 | 4 | CID000077804 | |
| Drug | NSC674039 | 2.21e-04 | 44 | 154 | 4 | CID000001249 | |
| Drug | NDPS | 2.42e-04 | 45 | 154 | 4 | CID000090363 | |
| Drug | 1IIg | 2.42e-04 | 45 | 154 | 4 | CID000001682 | |
| Drug | AC1L18MO | 2.70e-04 | 4 | 154 | 2 | CID000000168 | |
| Drug | 2-hydroxyisonicotinate | 2.70e-04 | 4 | 154 | 2 | CID000280756 | |
| Drug | BFNU | 2.70e-04 | 4 | 154 | 2 | CID000096886 | |
| Drug | Chebi:32701 | 2.70e-04 | 4 | 154 | 2 | CID005460855 | |
| Drug | ANA 2000 | 2.70e-04 | 4 | 154 | 2 | CID006336581 | |
| Drug | dehydroilludin M | 2.70e-04 | 4 | 154 | 2 | CID000168782 | |
| Disease | Chromosome Aberrations | 6.87e-05 | 16 | 150 | 3 | C0008625 | |
| Disease | Autosome Abnormalities | 6.87e-05 | 16 | 150 | 3 | C0004403 | |
| Disease | RHABDOMYOSARCOMA 2 | 7.68e-05 | 3 | 150 | 2 | 268220 | |
| Disease | alveolar rhabdomyosarcoma (is_implicated_in) | 7.68e-05 | 3 | 150 | 2 | DOID:4051 (is_implicated_in) | |
| Disease | Alveolar rhabdomyosarcoma | 7.68e-05 | 3 | 150 | 2 | cv:C0206655 | |
| Disease | facial morphology | 1.79e-04 | 55 | 150 | 4 | EFO_0004743 | |
| Disease | Lupus Erythematosus, Discoid | 2.54e-04 | 5 | 150 | 2 | C0024138 | |
| Disease | Alveolar rhabdomyosarcoma | 2.54e-04 | 5 | 150 | 2 | C0206655 | |
| Disease | megacystis-microcolon-intestinal hypoperistalsis syndrome (is_implicated_in) | 2.54e-04 | 5 | 150 | 2 | DOID:0060610 (is_implicated_in) | |
| Disease | cardiovascular measurement | 3.80e-04 | 6 | 150 | 2 | EFO_0004298 | |
| Disease | plasma serine protease inhibitor measurement | 3.80e-04 | 6 | 150 | 2 | EFO_0020642 | |
| Disease | squamous cell carcinoma | 3.83e-04 | 67 | 150 | 4 | EFO_0000707 | |
| Disease | Ectrodactyly | 5.30e-04 | 7 | 150 | 2 | C0265554 | |
| Disease | thrombin measurement | 7.04e-04 | 8 | 150 | 2 | EFO_0020768 | |
| Disease | Congenital Hand Deformities | 7.04e-04 | 8 | 150 | 2 | C0018566 | |
| Disease | adult respiratory distress syndrome (implicated_via_orthology) | 9.03e-04 | 9 | 150 | 2 | DOID:11394 (implicated_via_orthology) | |
| Disease | multiple sclerosis, chronic lymphocytic leukemia | 9.03e-04 | 9 | 150 | 2 | EFO_0000095, MONDO_0005301 | |
| Disease | Ceroid lipofuscinosis, neuronal 1, infantile | 1.12e-03 | 10 | 150 | 2 | C2931673 | |
| Disease | level of Phosphatidylcholine (16:0_20:3) in blood serum | 1.12e-03 | 10 | 150 | 2 | OBA_2045075 | |
| Disease | transmembrane glycoprotein NMB measurement | 1.12e-03 | 10 | 150 | 2 | EFO_0008303 | |
| Disease | peptidyl-glycine alpha-amidating monooxygenase measurement | 1.37e-03 | 11 | 150 | 2 | EFO_0801871 | |
| Disease | very long-chain saturated fatty acid measurement | 1.46e-03 | 44 | 150 | 3 | EFO_0006796 | |
| Disease | persulfide dioxygenase ETHE1, mitochondrial measurement | 1.64e-03 | 12 | 150 | 2 | EFO_0008258 | |
| Disease | X-12707 measurement | 1.64e-03 | 12 | 150 | 2 | EFO_0800720 | |
| Disease | vitamin D measurement | 1.71e-03 | 336 | 150 | 7 | EFO_0004631 | |
| Disease | transmembrane protein 87B measurement | 1.93e-03 | 13 | 150 | 2 | EFO_0802158 | |
| Disease | lymphocyte percentage of leukocytes | GAD2 WIPI1 MOSPD2 ADAP1 TENT4B PSMD2 EPS15L1 ELF1 UBASH3B RBM17 | 2.20e-03 | 665 | 150 | 10 | EFO_0007993 |
| Disease | disease recurrence, colon carcinoma | 2.24e-03 | 51 | 150 | 3 | EFO_0004952, EFO_1001950 | |
| Disease | ascorbic acid 3-sulfate measurement | 2.24e-03 | 14 | 150 | 2 | EFO_0800173 | |
| Disease | Dyskeratosis Congenita | 2.94e-03 | 16 | 150 | 2 | C0265965 | |
| Disease | pyroglutamine measurement | 3.24e-03 | 58 | 150 | 3 | EFO_0005408 | |
| Disease | glycoprotein measurement | 3.24e-03 | 119 | 150 | 4 | EFO_0004555 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 3.27e-03 | 195 | 150 | 5 | DOID:1574 (implicated_via_orthology) | |
| Disease | cortical surface area measurement | DNAJC13 RAPH1 SLC27A6 MAP2 STN1 VCAN EXOC6B ADAMTS20 MACF1 ELF2 PAX2 PAX3 PAX7 PLXNA2 DNAH11 | 3.63e-03 | 1345 | 150 | 15 | EFO_0010736 |
| Disease | Female Urogenital Diseases | 3.72e-03 | 18 | 150 | 2 | C1720887 | |
| Disease | Myeloid Leukemia | 3.72e-03 | 18 | 150 | 2 | C0023470 | |
| Disease | Leukemia, Monocytic, Chronic | 3.72e-03 | 18 | 150 | 2 | C0023466 | |
| Disease | Squamous cell carcinoma | 3.75e-03 | 124 | 150 | 4 | C0007137 | |
| Disease | peak expiratory flow | 4.07e-03 | 498 | 150 | 8 | EFO_0009718 | |
| Disease | neutrophil percentage of leukocytes | 4.11e-03 | 610 | 150 | 9 | EFO_0007990 | |
| Disease | mean arterial pressure | 4.12e-03 | 499 | 150 | 8 | EFO_0006340 | |
| Disease | brain connectivity measurement | 4.49e-03 | 400 | 150 | 7 | EFO_0005210 | |
| Disease | white matter hyperintensity measurement | 4.58e-03 | 302 | 150 | 6 | EFO_0005665 | |
| Disease | CCL4 measurement | 4.59e-03 | 20 | 150 | 2 | EFO_0004751 | |
| Disease | alpha-tocopherol measurement | 4.59e-03 | 20 | 150 | 2 | EFO_0007898 | |
| Disease | Disorder of eye | 4.66e-03 | 212 | 150 | 5 | C0015397 | |
| Disease | synophrys measurement | 5.07e-03 | 68 | 150 | 3 | EFO_0007906 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RPYNFFGILDKKKME | 196 | Q0P6H9 | |
| RQYVIPGMFKEVYQK | 601 | P21399 | |
| PGMFKEVYQKIETVN | 606 | P21399 | |
| AMYFIQQKVSKGIDP | 336 | Q9UBC2 | |
| KQMPQYRGRTEFVKD | 76 | Q6UXE8 | |
| EGQRLVYQFKEMPKD | 281 | P32519 | |
| YKDTLGPMQKELAEQ | 171 | O75821 | |
| VVENAKTFGKMKPRY | 3301 | P13611 | |
| FLENGQFKKREAFMP | 426 | P51589 | |
| NAYRNKERVKMVIFP | 321 | Q7Z5M8 | |
| FEVALPEYKQMKQCR | 1306 | Q96DT5 | |
| FIMKYKRGEINPVSA | 86 | Q96M93 | |
| KYFNRNDAKEPKAVM | 161 | O75689 | |
| KFNMDPAKGIQYFIE | 71 | Q9UIA0 | |
| YQESPGIQMKTRLKE | 711 | Q9UHI6 | |
| GVMKQEPFYLENIKN | 586 | Q6Q4G3 | |
| FEVVPGKNQKSEYVM | 641 | Q8WYQ5 | |
| LKIKVQDMDGQYFGL | 321 | Q02487 | |
| KGQNGEYFLEPIMKA | 156 | P59510 | |
| FSKRGSPEMVNYEKL | 241 | Q8N0U7 | |
| LYRGKDGKVMQAPIN | 396 | Q9Y2G4 | |
| FGKEGRFEMRPNVKY | 436 | P17342 | |
| MERIEKYALFKNPQN | 351 | Q70E73 | |
| FMVYNRTRVKEPIGK | 51 | Q9ULC6 | |
| GDRVYTLKKFDPMGQ | 11 | Q9NPE3 | |
| REKFEKVPGKYDMLQ | 191 | Q9UGN5 | |
| KKIEEYKRENPGMFS | 116 | P23759 | |
| VEKIAEYKRQNPTMF | 96 | Q02548 | |
| VAFKMRFKTQEYPEG | 1771 | O00763 | |
| AKDEVQKNMLDGYRP | 341 | Q8NDF8 | |
| RTMGKNPEIEKKYFE | 176 | Q9H867 | |
| KNREGYEMVFDGKPQ | 486 | Q05329 | |
| NMKKARVIQIIPYDF | 451 | P23469 | |
| CRMQVDPQKYKGIFN | 91 | Q00325 | |
| PEGAFMKVLQARKNY | 1066 | O60309 | |
| ANYESPGKIFLRMKE | 106 | Q6P0N0 | |
| YIPGKKFGEDIDQQM | 436 | Q4G0Z9 | |
| PKLFEELGKQIQQYM | 696 | P34932 | |
| PEGAFMKVLQARKNY | 1066 | A6NM11 | |
| PEGAFMKVLQARKNY | 1066 | A6NMS7 | |
| PIKDNALVMFNGKVY | 351 | Q5T3J3 | |
| KEDGMLPKNRTVYKN | 306 | Q92823 | |
| VYPMKFLQGEKQARV | 151 | Q6W5P4 | |
| RITGDPYKVQQAKEM | 236 | Q96AE4 | |
| VEGQRLVYQFKEMPK | 281 | Q99607 | |
| QQMPIVYKEKSGAVR | 1401 | O75882 | |
| KEREKQMLAQGYPAY | 176 | Q7L5Y1 | |
| EMYREAPIDKKGNFN | 141 | P24844 | |
| LYCAIKQQMEKGPID | 1461 | O75051 | |
| MLFRAIQYQVDKGPV | 1476 | Q9ULL4 | |
| AGDYPQVMKDYIGRK | 296 | Q6UWM7 | |
| MEKFRLEQKVYFKGQ | 71 | O43924 | |
| KEYETVMKGLDRNAP | 221 | Q12996 | |
| QKGIIYRDLKPENIM | 211 | P23443 | |
| PIFKNGDYNEVMKTR | 1631 | P09848 | |
| LEKMNVKIPENIYRG | 611 | P42704 | |
| NKPYEKVRIYRMDGS | 416 | O00522 | |
| PNQMVRIYKDGKVLY | 171 | P78334 | |
| NYIPEMVELFANKRK | 306 | A8MYU2 | |
| DLMYHIQQLGKFKEP | 441 | P05129 | |
| EMQERYFEPLVKKEQ | 751 | Q7L590 | |
| MNRYVKPGLKNNLEE | 196 | Q8WVL7 | |
| SEEMYKKVVGQFPFQ | 461 | Q9Y2D4 | |
| PEVENYLKEGFMNKE | 11 | Q8TEA1 | |
| LNGKDGFIPKNYIEM | 41 | P62993 | |
| PGMVELFNFIRKNKD | 76 | Q8TCD6 | |
| RMIDGKPEYKNGLDV | 251 | Q02978 | |
| YEDLKQPMAERKAQL | 3531 | Q9UPN3 | |
| MVKENFKARPGQYIT | 326 | Q9NPH5 | |
| VDKIAEYKRQNPTMF | 96 | Q02962 | |
| PFIYSLRNKDMKQGL | 336 | Q8NH94 | |
| PNKGYIYVVKVMREN | 1381 | O00750 | |
| KKIEEYKRENPGMFS | 116 | P23760 | |
| NPMVYALKNKELRQG | 296 | Q8NGI1 | |
| QGAVIRAMPVYKKAE | 221 | Q9H3D4 | |
| FERYMVNLQVKGKPV | 51 | O00212 | |
| RGLFAVFYDMDPQKK | 691 | Q8NB78 | |
| KKMGGEEFSRRYLQQ | 406 | Q8WXF7 | |
| IQKGLEPRKMYQYGA | 921 | P20023 | |
| RNITVKVQFMYGEDP | 581 | Q96N67 | |
| PQEGLYNELQKDKMA | 106 | P20963 | |
| QHFREKLPSYGMQKE | 201 | Q9H2U1 | |
| YKMTDKNFLGRPVEV | 1326 | P01031 | |
| NKVPLVEVKAYRQMA | 586 | Q6TDU7 | |
| MKPDGREFFQQIIEY | 66 | Q6ZWL3 | |
| NPEGRDMFEKVNKAY | 1336 | O75165 | |
| EGQRLVYQFKDMPKN | 281 | Q15723 | |
| VNPMINGIVKYRFEE | 81 | Q6GMR7 | |
| VKTFNMDEYVGLPRN | 66 | Q8TDQ7 | |
| MVAENILGQPKRYKG | 451 | Q9ULK0 | |
| IGRYPFKVLNKNGMV | 116 | P48723 | |
| PKGIRRKQFEEMASY | 1231 | Q5T890 | |
| TPEYMEKIKQRLFEN | 356 | Q92769 | |
| YEMIAGQSPFQQRKK | 376 | P43250 | |
| QVYMDIKIGNKPAGR | 141 | Q9UNP9 | |
| IEKVKNGYVNPELAM | 271 | Q9UMX9 | |
| DPDLYKQMEKFRKVQ | 181 | Q05084 | |
| YRPFVDKALKQMGLR | 526 | Q9Y6R4 | |
| YAKRENGKPVTVMFD | 136 | Q8NHP6 | |
| KQGIKALDFMRHQPY | 841 | Q9H987 | |
| IFLQNKYRENNKGPM | 126 | P08247 | |
| KYRENNKGPMLDFLA | 131 | P08247 | |
| RDMNQVLDAYENKKP | 141 | P23381 | |
| VYNKDGPDFLAMELK | 1756 | O75445 | |
| FRPLMEKVEVKNYDA | 311 | Q969X6 | |
| DMKESRQVPGVFLYN | 36 | Q9H668 | |
| PQNLEEFYEKFMSGK | 161 | Q6IMI6 | |
| YKEQVLEPMLNGTDK | 956 | Q02880 | |
| MNKYDLSGRPLNIKE | 161 | Q9P2K5 | |
| AAMVQQYGKRRKQPE | 676 | Q8NI08 | |
| LKEIYENMAPGENKR | 106 | Q13200 | |
| YDVKAPAMFNIRNIG | 31 | P61247 | |
| NMVSKRIEDYGLKPV | 486 | Q96PZ0 | |
| VRNADPIAKYLQKEM | 731 | Q7Z7L1 | |
| MYAVFNKGKPIFEVN | 256 | Q6P3W7 | |
| IAVGRMQKGIDYVKN | 1006 | Q9NY46 | |
| LEFPAQELRKYFKMG | 461 | O00267 | |
| NTEEMKLKNPGRYQI | 116 | B9A6J9 | |
| LFYEDMKENPKREIQ | 191 | P0DMN0 | |
| LFYEDMKENPKREIQ | 191 | P0DMM9 | |
| DEIKQGFNFRKMPEK | 96 | Q8IW75 | |
| FGMLKSVKEYVDPNN | 636 | O00116 | |
| ARNPMKKTEEIYGFL | 306 | O43916 | |
| KYAKDDMNIRDQPFG | 106 | Q86X95 | |
| KKGMFRTVGQLYKEQ | 646 | P35749 | |
| LFYQKQMQLRKGKDP | 506 | O94762 | |
| NIEEMKLKNPGRYQI | 116 | A6NDS4 | |
| NTEEMKLKNPGRYQI | 116 | P0C7X1 | |
| KPVYEIQGVMKFRKD | 226 | Q8N1K5 | |
| DKAQIREKPSQGIYM | 111 | Q8IWS0 | |
| RYIGKLPFEQAESNM | 531 | Q9H270 | |
| LPFEQAESNMKRYGK | 536 | Q9H270 | |
| NPLASKEMERIKGYQ | 1441 | Q8IZQ1 | |
| KDALQEIYNQKGMFP | 281 | Q9NRZ7 | |
| EIYNQKGMFPGEQFK | 286 | Q9NRZ7 | |
| GVYQKGMDFILEKLN | 126 | Q16635 | |
| NIEEMKLKNPGRYQI | 116 | A6NER0 | |
| LFYEDMKENPKREIQ | 191 | P50225 | |
| LFYEDMKENPKREIQ | 191 | P50226 | |
| APFEVRLYKNKDMIQ | 111 | Q9UNG2 | |
| DPMFPNDYEKVVKRQ | 101 | Q96I25 | |
| QREKVDPKDYMFSGL | 31 | O75695 | |
| YVVDKLNFKPLEQEM | 876 | O43847 | |
| NFGYELPAVEAAMKK | 456 | Q9H254 | |
| NTEEMKLKNPGRYQI | 116 | A0A087X179 | |
| EYKPELQKAMEFVFG | 611 | O95347 | |
| LGPSQKKLYRDVMQE | 21 | Q8N972 | |
| QERMFTIDPKVYGEK | 656 | P11137 | |
| VRKDPYVQMDKGVLQ | 286 | Q9H8X9 | |
| KMVNFPQKIAGELYG | 141 | Q9GZM5 | |
| ADSRQRPQMKVNEYK | 11 | Q9H967 | |
| LQMNPRDFKEKYNEV | 76 | H0UI37 | |
| NTEEMKLKNPGRYQI | 116 | A0A087WVF3 | |
| KDFVQMVRKIPYLGF | 596 | Q8TF42 | |
| VPDGQKLYEFRRGMK | 216 | Q5MNZ9 | |
| EVPYKMVKGFSNRAR | 701 | Q01831 | |
| VRKDPYVQMDKGFLQ | 286 | P0C7U3 | |
| IKYDFQKDEPMRNEQ | 396 | Q9Y2P4 | |
| NIEEMKLKNPGRYQI | 116 | Q6DHY5 | |
| NTEEMKLKNPGRYQI | 116 | Q8IZP1 | |
| QEEQYNRFMKLVGGK | 481 | O60293 | |
| KNDPDYIVMQFGRVA | 396 | O75386 | |
| NIEEMKLKNPGRYQI | 116 | A0A087X1G2 | |
| NTEEMKLKNPGRYQI | 116 | Q6IPX1 | |
| IPRKEKDFQGMLEYK | 1466 | Q9Y4I1 | |
| PDNYQVGKTMVFLKE | 991 | B2RTY4 |